Compare ACH & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACH | BSEM |
|---|---|---|
| Founded | 1882 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.4M | 76.9M |
| IPO Year | 2001 | 2026 |
| Metric | ACH | BSEM |
|---|---|---|
| Price | $0.25 | $1.12 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.26 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 143.3K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,762,032,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.97 | $87.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.19 | $1.21 |
| 52 Week High | $4.69 | $5.44 |
| Indicator | ACH | BSEM |
|---|---|---|
| Relative Strength Index (RSI) | 25.02 | 21.94 |
| Support Level | $0.19 | N/A |
| Resistance Level | $1.26 | $4.65 |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 28.44 | 1.45 |
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.